Another Paragon spinout goes public through reverse merger
BioPharma DiveJacob BellOctober 13, 2026
One lawyer involved in the deal noted how it's yet another example of Paragon and key investor Fairmount which have helped transform the once-unsavory reputation for reverse mergers quickly executing on a complicated transaction.
